Fig. 4From: Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centersSatisfaction with Onabotulinumtoxin A (OBT-A) treatment: a treatment satisfaction of clinicians; b treatment satisfaction of patients (as perceived by clinicians). Treatment satisfaction was rated on a scale from 0 (no satisfaction) to 10 (highest satisfaction)Back to article page